These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 22208729)

  • 21. Structural basis of steroid binding and oxidation by the cytochrome P450 CYP109E1 from Bacillus megaterium.
    Jóźwik IK; Kiss FM; Gricman Ł; Abdulmughni A; Brill E; Zapp J; Pleiss J; Bernhardt R; Thunnissen AW
    FEBS J; 2016 Nov; 283(22):4128-4148. PubMed ID: 27686671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11.
    Vottero E; Rea V; Lastdrager J; Honing M; Vermeulen NP; Commandeur JN
    J Biol Inorg Chem; 2011 Aug; 16(6):899-912. PubMed ID: 21567268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the oxidation of short chain alkynes by flavocytochrome P450 BM3.
    Waltham TN; Girvan HM; Butler CF; Rigby SR; Dunford AJ; Holt RA; Munro AW
    Metallomics; 2011 Apr; 3(4):369-78. PubMed ID: 21431175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phe393 mutants of cytochrome P450 BM3 with modified heme redox potentials have altered heme vinyl and propionate conformations.
    Chen Z; Ost TW; Schelvis JP
    Biochemistry; 2004 Feb; 43(7):1798-808. PubMed ID: 14967021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxygen activation and electron transfer in flavocytochrome P450 BM3.
    Ost TW; Clark J; Mowat CG; Miles CS; Walkinshaw MD; Reid GA; Chapman SK; Daff S
    J Am Chem Soc; 2003 Dec; 125(49):15010-20. PubMed ID: 14653735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxylation of non-substituted polycyclic aromatic hydrocarbons by cytochrome P450 BM3 engineered by directed evolution.
    Sideri A; Goyal A; Di Nardo G; Tsotsou GE; Gilardi G
    J Inorg Biochem; 2013 Mar; 120():1-7. PubMed ID: 23262457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of cytochrome P450 BM3 phenylalanine-87 and threonine-268 in binding organic hydroperoxides.
    Roberts AG; Katayama J; Kaspera R; Ledwitch KV; Le Trong I; Stenkamp RE; Thompson JA; Totah RA
    Biochim Biophys Acta; 2016 Apr; 1860(4):669-77. PubMed ID: 26723172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural analysis of Cytochrome P450 BM3 mutant M11 in complex with dithiothreitol.
    Frydenvang K; Verkade-Vreeker MCA; Dohmen F; Commandeur JNM; Rafiq M; Mirza O; Jørgensen FS; Geerke DP
    PLoS One; 2019; 14(5):e0217292. PubMed ID: 31125381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving the activity of cytochrome P450 BM-3 catalyzing indole hydroxylation by directed evolution.
    Pengpai Z; Sheng H; Lehe M; Yinlin L; Zhihua J; Guixiang H
    Appl Biochem Biotechnol; 2013 Sep; 171(1):93-103. PubMed ID: 23817788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regioselectivity-driven evolution of CYP102D1 for improved synthesis of 3'-ortho-dihydroxyisoflavone.
    Choi KY; Yang YH; Kim BG
    Enzyme Microb Technol; 2015 Apr; 71():20-7. PubMed ID: 25765306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis for the properties of two single-site proline mutants of CYP102A1 (P450BM3).
    Whitehouse CJ; Yang W; Yorke JA; Rowlatt BC; Strong AJ; Blanford CF; Bell SG; Bartlam M; Wong LL; Rao Z
    Chembiochem; 2010 Dec; 11(18):2549-56. PubMed ID: 21110374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions.
    Dietrich M; Do TA; Schmid RD; Pleiss J; Urlacher VB
    J Biotechnol; 2009 Jan; 139(1):115-7. PubMed ID: 18984016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into electron leakage in the reaction cycle of cytochrome P450 BM3 revealed by kinetic modeling and mutagenesis.
    Lim JB; Barker KA; Eller KA; Jiang L; Molina V; Saifee JF; Sikes HD
    Protein Sci; 2015 Nov; 24(11):1874-83. PubMed ID: 26311413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of human chiral metabolites of simvastatin and lovastatin by bacterial CYP102A1 mutants.
    Kim KH; Kang JY; Kim DH; Park SH; Park SH; Kim D; Park KD; Lee YJ; Jung HC; Pan JG; Ahn T; Yun CH
    Drug Metab Dispos; 2011 Jan; 39(1):140-50. PubMed ID: 20962060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of tryptophan 97 of cytochrome P450 BM3 from Bacillus megaterium in catalytic function. Evidence against the 'covalent switching' hypothesis of P-450 electron transfer.
    Munro AW; Malarkey K; McKnight J; Thomson AJ; Kelly SM; Price NC; Lindsay JG; Coggins JR; Miles JS
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):423-8. PubMed ID: 7980400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
    Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
    Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Enzymatic Route to α-Tocopherol Synthons: Aromatic Hydroxylation of Pseudocumene and Mesitylene with P450 BM3.
    Dennig A; Weingartner AM; Kardashliev T; Müller CA; Tassano E; Schürmann M; Ruff AJ; Schwaneberg U
    Chemistry; 2017 Dec; 23(71):17981-17991. PubMed ID: 28990705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
    Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
    Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are branched chain fatty acids the natural substrates for P450(BM3)?
    Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
    Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly regioselective hydroxylation of polydatin, a resveratrol glucoside, for one-step synthesis of astringin, a piceatannol glucoside, by P450 BM3.
    Le TK; Jang HH; Nguyen HT; Doan TT; Lee GY; Park KD; Ahn T; Joung YH; Kang HS; Yun CH
    Enzyme Microb Technol; 2017 Feb; 97():34-42. PubMed ID: 28010771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.